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Objective
To assess the contribution of papillary muscles and trabec-
ulae (PMT) to left ventricular (LV) quantification in
patients with and without LV hypertrophy.
Background
Accurate assessment of left ventricular mass (LVM) and
ejection fraction (EF) is of diagnostic importance for
patients with LV hypertrophy (LVH). Cardiac magnetic
resonance imaging (CMR) has been proposed as a stand-
ard for these indices. However, prior CMR studies have
variably included papillary muscles/trabeculae (PMT) in
intracavitary or myocardial volume. The relative impact of
this methodologic variability on LVH patients is
unknown.
Methods
Patients with established concentric (CLVH) or eccentric
hypertrophy (ELVH) independently verified by echocardi-
ography were studied by CMR (1.5 T) and compared to a
group of 20 low risk patients with normal LVM and geom-
etry (NL). In all patients, short axis SSFP images were
acquired contiguously through the LV (typical parame-
ters: TR 3.5 msec, TE 1.6 msec, flip angle 60°, 6 mm slice
thickness/4 mm gap). LV volumes were determined by
two established methods: method 1 included PMT in
myocardial volume, method 2 included PMT in intracavi-
tary volume. Both methods were used for each patient
with tracings superimposed to isolate PMT and ensure
endocardial and epicardial contour consistency. Each
method was applied blinded to results of the other tech-
nique.
Results
In the 60 total patients (40 LVH/20 NL), PMT accounted
for 10.5% of total LVM, with over a 2-fold difference
between LVH and NL pts (12.6 vs 6.2%, p < 0.001). LV
mass quantification with PMT exclusion (method 2) pro-
duced a 37% reduction (p < 0.001) in patients meeting
gender-specific LVH criteria using previously established
CMR definitions based on PMT inclusion (method 1).
PMT correlated with LV wall mass (r = 0.67) and end
diastolic volume (EDV) (r = 0.68; p < 0.001). Method var-
iability yielded differences in LVEF, EDV, and LVM within
all groups (Table 1), but differences were greater in LVH
patients: ΔLVM index was > 3-fold greater in CLVH and >
6-fold greater in ELVH vs. NL (p < 0.001). ΔEF was > 2-
fold higher in CLVH vs. NL (p < 0.001). In multivariable
analysis, ΔEF was independently related to PMT mass, LV
wall mass, and EDV (R2 = 0.56, p < 0.001).
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Established CMR methods can yield differences in LV
quantification due to variable exclusion of PMT from
myocardium. Impact of PMT exclusion on calculated LVM
and EF is increased in patients with hypertrophy-associ-
ated LV remodeling.
Table 1: Methodological variance in LV volumetric and functional parameters
Normal p Eccentric LVH p Concentric LVH p
Myocardial Mass Index (g/m2) (method 1) 52.4 ± 8.9 134.6 ± 29.7 123.6 ± 17.7
Myocardial Mass Index (g/m2) (method 2) 49.4 ± 9.0 113.7 ± 26.0 111.6 ± 15.2
Δ Myocardial Mass Index (g/m2) 3.1 ± 0.7 < 0.001 20.9 ± 8.9 < 0.001 12.0 ± 4.3 < 0.001
Ejection Fraction (%) (method 1) 68.2 ± 6.4 21.8 ± 9.2 59.8 ± 15.1
Ejection Fraction (%) (method 2) 64.8 ± 6.2 19.4 ± 8.4 52.7 ± 13.4
Δ Ejection Fraction (%) 3.4 ± 1.0 < 0.001 2.4 ± 1.3 < 0.001 7.1 ± 13.4 < 0.001
End Diastolic Volume (cc) (method 1) 134.8 ± 39.9 282.5 ± 60.1 137.9 ± 27.8
End Diastolic Volume (cc) (method 2) 140.4 ± 40.6 320.5 ± 70.6 160.1 ± 27.8
Δ End Diastolic Volume (cc) 5.6 ± 1.7 < 0.001 37.9 ± 17.3 < 0.001 22.2 ± 7.4 < 0.001Page 2 of 2
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